<DOC>
	<DOCNO>NCT03003156</DOCNO>
	<brief_summary>This trial attempt investigate whether dosage ( frequency ) effect treatment efficacy cognitive outcome magnetic seizure therapy ( MST ) among schizophrenia patient . Half participant recruit receive 25 Hz MST , half recruit 50 Hz MST .</brief_summary>
	<brief_title>50 Hz vs. 25 Hz Magnetic Seizure Therapy Schizophrenia</brief_title>
	<detailed_description>Magnetic seizure therapy ( MST ) likely alternative option electroconvulsive therapy ( ECT ) .Widespread stimulation cortical subcortical region inevitable ECT since substantial impedance scalp skull shut electrical stimulus away brain . Nevertheless , magnetic pulse capable focus stimulus specific area brain pas scalp skull without resistance . In Addition , electric current penetrate deeper structure , magnetic stimulus capable reach depth centimeter . As consequence , MST able generate focus stimuli superficial region cortex ECT ca n't , may give MST capability produce comparable therapeutic benefit absence apparent cognitive side effect . Though high dose ( frequency ) MST gain popularity , evidence support superiority low dose ( frequency ) MST either efficacy , safety , seizure quality .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>1 . DSM5 diagnosis schizophrenia ; 2. convulsive therapy clinically indicate , severe psychomotor excitement retardation , attempt suicide , highly aggressive , pharmacotherapy intolerance , ineffectiveness antipsychotic ; 3. positive negative syndrome scale ( PANSS ) [ 20 ] score â‰¥ 60 ; 4. informed consent write form . 1. diagnosis mental disorder ; 2. severe physical disease , stroke , heart failure , liver failure , neoplasm , immune deficiency ; 3. present laboratory abnormality could impact efficacy treatment safety participant ; 4. failure respond adequate trial ECT lifetime ; 5. pregnant intend get pregnant study ; 6. condition investigator consider inappropriate participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>magnetic seizure therapy</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>control trial</keyword>
	<keyword>cognition</keyword>
</DOC>